Literature DB >> 15654938

Dark therapy for mania: a pilot study.

Barbara Barbini1, Francesco Benedetti, Cristina Colombo, Danilo Dotoli, Alessandro Bernasconi, Mara Cigala-Fulgosi, Marcello Florita, Enrico Smeraldi.   

Abstract

BACKGROUND: Recent findings suggest that extended bed rest and darkness could stabilize mood swings in rapid cycling bipolar patients.
METHOD: We exposed 16 bipolar inpatients affected by a manic episode to a regimen of 14 h of enforced darkness from 6 p.m. to 8 a.m. each night for three consecutive days [dark therapy (DT)]. Pattern of mood changes were recorded with the Young Mania Rating Scale (YMRS) and compared with a control group of 16 inpatients matched for age, sex, age at onset, number of previous illness episodes and duration of current episode, and were treated with therapy as usual (TAU).
RESULTS: Adding DT to TAU resulted in a significantly faster decrease of YMRS scores when patients were treated within 2 weeks from the onset of the current manic episode. When duration of current episode was longer, DT had no effect. Follow-up confirmed that good responders needed a lower dose of antimanic drugs and were discharged earlier from the hospital.
CONCLUSIONS: Chronobiological interventions and control of environmental stimuli can be a useful add-on for the treatment of acute mania in a hospital setting. Copyright (c) 2005, Blackwell Munksgaard.

Entities:  

Mesh:

Year:  2005        PMID: 15654938     DOI: 10.1111/j.1399-5618.2004.00166.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  30 in total

Review 1.  Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms.

Authors:  Allison G Harvey; Greg Murray; Rebecca A Chandler; Adriane Soehner
Journal:  Clin Psychol Rev       Date:  2010-04-24

Review 2.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 3.  Illuminating rationale and uses for light therapy.

Authors:  Afshin Shirani; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

4.  Sleep and Circadian Rhythm Disorder in Bipolar Affective Disorder.

Authors:  Attia Ahmad; Kirstie N Anderson; Stuart Watson
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 5.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 6.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 7.  Basic sleep and circadian science as building blocks for behavioral interventions: a translational approach for mood disorders.

Authors:  Lauren D Asarnow; Adriane M Soehner; Allison G Harvey
Journal:  Behav Neurosci       Date:  2014-04-28       Impact factor: 1.912

8.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls

Authors:  Philipp Ritter; Falk Wieland; Debra J. Skene; Andrea Pfennig; Maria Weiss; Michael Bauer; Emanuel Severus; Henry Güldner; Cathrin Sauer; Bettina Soltmann; Stefanie Neumann
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

Review 9.  Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges.

Authors:  Ruth Benca; Marilyn J Duncan; Ellen Frank; Colleen McClung; Randy J Nelson; Aleksandra Vicentic
Journal:  Brain Res Rev       Date:  2009-09-18

10.  Cyclin-dependent kinase 5 (Cdk5) regulates the function of CLOCK protein by direct phosphorylation.

Authors:  Yongdo Kwak; Jaehoon Jeong; Saebom Lee; Young-Un Park; Seol-Ae Lee; Dong-Hee Han; Joung-Hun Kim; Toshio Ohshima; Katsuhiko Mikoshiba; Yoo-Hun Suh; Sehyung Cho; Sang Ki Park
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.